Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region. Issue 1 (December 2015)
- Record Type:
- Journal Article
- Title:
- Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region. Issue 1 (December 2015)
- Main Title:
- Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region
- Authors:
- Yu, Yang
Gao, Qian
Zhao, Hong-cui
Li, Rong
Gao, Jiang-man
Ding, Ting
Bao, Si-yu
Zhao, Yue
Sun, Xiao-fang
Fan, Yong
Qiao, Jie - Abstract:
- Abstract Introduction Human parthenogenetic embryonic stem cells (hpESCs) are generated from artificially activated oocytes, however, the issue of whether hpESCs have equivalent differentiation ability to human fertilized embryonic stem cells remains controversial. Methods hpESCs were injected into male severe combined immunodeficiency (SCID) mice and the efficiency of teratoma formation was calculated. Then the gene expression and methylation modification were detected by real time-PCR and bisulfate methods. Results Comparison of five hpESCs with different differentiation abilities revealed that levels of paternal genes in the Dlk1-Dio3 region on chromosome 14 in the hpESCs with high differentiation potential are enhanced, but strictly methylated and silenced in the hpESCs with lower differentiation potential. Treatment with ascorbic acid, rescued their ability to support teratoma formation and altered the expression profiles of paternally expressed genes in hpESCs that could not form teratoma easily. No differences in the expression of other imprinting genes were evident between hpESCs with higher and lower differentiation potential, except for those in the Dlk1-Dio3 region. Conclusions The Dlk1-Dio3 imprinting gene cluster distinguishes the differentiation ability of hpESCs. Moreover, modification by ascorbic acid may facilitate application of hpESCs to clinical settings in the future by enhancing their pluripotency.
- Is Part Of:
- Stem cell research & therapy. Volume 6:Issue 1(2015)
- Journal:
- Stem cell research & therapy
- Issue:
- Volume 6:Issue 1(2015)
- Issue Display:
- Volume 6, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 6
- Issue:
- 1
- Issue Sort Value:
- 2015-0006-0001-0000
- Page Start:
- 1
- Page End:
- 12
- Publication Date:
- 2015-12
- Subjects:
- Stem cells -- Research -- Periodicals
Cellular therapy -- Periodicals
616.0277405 - Journal URLs:
- http://stemcellres.com/ ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1238/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s13287-015-0054-9 ↗
- Languages:
- English
- ISSNs:
- 1757-6512
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9922.xml